-------如果这里没有任何信息，不是真没有，是我们懒！请复制书名上amazon搜索书籍信息。-------
2024 Update in Clinical Cardiology: October 16-18, 2024
COURSE OVERVIEW
Update in Clinical Cardiology provides comprehensive updates for state-of-the-art care and guidance to incorporate them into daily practice to optimize patient outcomes. Coverage includes:
- Coronary Artery Disease
- Diabetes and Obesity
- Valvular Heart Disease
- Cardiac Biomarkers
- Heart Failure (reduced and preserved ejection fraction)
- Pulmonary Hypertension
- Cardiomyopathies
- Dyslipidemia
- Hypertension
- Atrial Fibrillation
- Supraventricular Tachycardia
- Ventricular Arrhythmias
- Thoracic Aortic Disease
- Pericarditis
- Peripheral Arterial Disease
- Renal Artery Stenosis
- Pulmonary Embolism and Venous Thromboembolism
- Cardio-oncology
- Adult Congenital Heart Disease
- Cardiac Critical Care
- Ischemia with Non-Obstructive Coronary Arteries (INOCA)
- Spontaneous Coronary Artery Dissection (SCAD)
- Heart Disease in Pregnancy
- Sports Cardiology
- Endocarditis
The faculty is assembled from the best clinician-educators at Harvard Medical School and Massachusetts General Hospital and is designed to deliver the highest quality educational experience:
- Teaching practical, effective clinical reasoning and approaches that enable you to practice state-of-the-art clinical cardiology
- Allowing ample time for participants to interact with faculty and to pose and get answers to your specific questions, including Q&A sessions and case-based panel discussions
- Providing the latest information in an engaging manner and clinically usable context so that you have knowledge you can “take home” and immediately apply to patient care
2024 PROGRAM HIGHLIGHTS
- Management of obesity and diabetes for improved cardiovascular health outcomes
- Use of GLP-1 agonists and SGLT2-inhibitors
- Thoracic aortic disease Guideline Writing Committee chair, Dr. Eric M. Isselbacher, presents and answers your questions about the new guidelines for diagnosis and treatment
- New clinical trials: data findings, updates, and implications for daily practice
- Novel transcatheter and structural treatment options: important updates for the management of valvular disease
- Optimized approaches to heart failure and cardiomyopathies, including hypertrophic cardiomyopathy and cardiac amyloidosis
- Advances in electrical devices and mechanical support
- Complex coronary artery disease management in the cath lab with novel diagnostic and revascularization techniques
- Artificial intelligence (AI) and cardiovascular medicine
